Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1-3 studies.

Gladman DD, Kavanaugh A, Gómez-Reino JJ, Wollenhaupt J, Cutolo M, Schett G, Lespessailles E, Guerette B, Delev N, Teng L, Edwards CJ, Birbara CA, Mease PJ

Open source

DOI
10.1136/rmdopen-2018-000669
Published
2018
Container
RMD open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/rmdopen-2018-000669,
  title = {Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1-3 studies.},
  author = {Gladman DD and Kavanaugh A and Gómez-Reino JJ and Wollenhaupt J and Cutolo M and Schett G and Lespessailles E and Guerette B and Delev N and Teng L and Edwards CJ and Birbara CA and Mease PJ},
  year = {2018},
  journal = {RMD open},
  doi = {10.1136/rmdopen-2018-000669},
  url = {https://doi.org/10.1136/rmdopen-2018-000669}
}

RIS

TY  - JOUR
TI  - Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1-3 studies.
AU  - Gladman DD
AU  - Kavanaugh A
AU  - Gómez-Reino JJ
AU  - Wollenhaupt J
AU  - Cutolo M
AU  - Schett G
AU  - Lespessailles E
AU  - Guerette B
AU  - Delev N
AU  - Teng L
AU  - Edwards CJ
AU  - Birbara CA
AU  - Mease PJ
PY  - 2018
JO  - RMD open
DO  - 10.1136/rmdopen-2018-000669
UR  - https://doi.org/10.1136/rmdopen-2018-000669
ER  - 

APA

DD, G., A, K., JJ, G., J, W., M, C., G, S., E, L., B, G., N, D., L, T., CJ, E., CA, B., & PJ, M. (2018). Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1-3 studies.. RMD open. https://doi.org/10.1136/rmdopen-2018-000669

Source records